Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis

Turbo-Tandem® and Turbo Elite® are indicated to treat peripheral ISR, the only on-label products in the industry

EXCITE clinical trial proves safety, efficacy of laser technology

COLORADO SPRINGS, COLO. (July 23, 2014) – The Spectranetics Corporation today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem and Turbo Elite, for the treatment of in-stent restenosis (ISR). The clearance prompts a new standard of care in ISR treatment with improved clinical outcomes.

Radiation Exposure Concerns, Increased Precision Driving Growth of Corindus Vascular Robotics

Robotic-assisted coronary angioplasties a solution today for hospitals across the country
Waltham, MA – July 23, 2014 – As attention increases on the effects of radiation exposure among interventional cardiologists(1), Corindus Vascular Robotics announced the recent installations of its CorPath System at five facilities:

ACE Broadens its Accreditation and Quality Review Services to Include all Invasive Cardiovascular Specialties

Accreditation for Cardiovascular Excellence (ACE) Launches Four New Programs

"ACE is growing rapidly. In 2013, we doubled our number of accredited facilities and in 2014, we expect to continue this trend."
— Bonnie Weiner, MD, Chief Medical Officer, ACE

Boston Scientific Receives CE Mark For the New 25 mm Lotus™ Valve System

European Launch Means Physicians Can Now Choose From Three Available Valve Sizes To Match Patient Anatomy More Precisely

MARLBOROUGH, Mass., July 14, 2014 —  Boston Scientific Corporation has received CE Mark and begun the European commercial launch of its new 25 mm Lotus™ Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.

Cordis Corporation Launches SABER™ PTA Dilatation Catheter, a High-Performance Balloon Catheter for PAD

Fremont, Calif., July 1, 2014 – Cordis Corporation announced today the launch of its SABER™ PTA Dilatation Catheter for the treatment of patients with peripheral arterial disease (PAD). The Saber catheter is cleared for use and now available in Europe, the United States and Japan. It offers outstanding crossability and a comprehensive offering of balloon sizes on the widely-used .018” over-the-wire platform. Physicians can now treat a wider range of PAD patients with a single balloon brand.

Volume 26 - Issue 7 - July 2014

Volume Number: 
Issue Number: 
Journal Date: 
July 2014
12 345
Publish Date: 
07/09/2014 - 08:00

First European Experience with Innovative Guidewire at St George’s Hospital London, UK

London, United Kingdom (July 1st, 2014) – The first cases using the ProTrack Pigtail Wire (Baylis Medical) in Europe were performed last month at St George’s Hospital in London. The ProTrack Pigtail Wire is used during the transseptal procedure, a challenging minimally invasive technique used to cross the septum of the heart.

Back to top